Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David H Dreyfus
Evidence That Raltegravir (Isentress, Merck), a Retroviral Integrase Inhibitor Is Effective Against Recurrent Human Herpes Simplex Virus Infection Associated With NK-cell Deficiency
Pediatrics & Therapeutics
Related publications
Early Onset of Autoimmune Disease by the Retroviral Integrase Inhibitor Raltegravir
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Congenital Herpes Simplex Virus Infection
Herpes Simplex Virus Glycoproteins as Treatment for Recurrent Genital Herpetic Infection
Pediatric Research
Child Health
Pediatrics
Perinatology
Evidence That Two Latency-Associated Transcripts of Herpes Simplex Virus Type 1 Are Nonlinear.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Topical Tenofovir, a Microbicide Effective Against HIV, Inhibits Herpes Simplex Virus-2 Replication
Cell Host and Microbe
Immunology
Molecular Biology
Cancer Research
Virology
Microbiology
Microbiology
Parasitology
Protective Antibody Therapy Is Associated With Reduced Chemokine Transcripts in Herpes Simplex Virus Type 1 Corneal Infection.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Recurrent Herpes Simplex Type 2 Virus (Mollaret) Meningitis
Journal of the American Board of Family Medicine
Environmental
Public Health
Family Practice
Occupational Health
Ribonucleotide Reductase of Herpes Simplex Virus Type 2 Resembles That of Herpes Simplex Virus Type 1.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Mutations Associated With Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor in Vitro
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
